TareBio
Vaccines for any cancer or infection in weeks.
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Our platform develops personalized or population-level vaccines for any disease in weeks by changing only one input: the immune imprint. Instead of trying to predict which antigens might work, we read out immune cells already fighting the disease in the body and reverse-engineer antigens that activate them. We've already run our platform end-to-end and created a vaccine that cured cancer in mice. TareBio is a Y Combinator company (Summer 2026). YC-listed status: Active.
- Website
- tarebio.com
- Location
- San Francisco, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- TareBio — Biotechnology platform that reverse-engineers immune-activating antigens from patient immune cells to develop personalized vaccines rapidly. · Service · Enterprise
Links
- Y Combinator profileycombinator